Oryzon Genomics

0 followers


Oryzon Genomics is a clinical‐stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases.

Industries

+2

Headquarters

Stage

Employees

Links

Org chart

Carlos Buesa
CEO & Director

Carlos Buesa

Collapse
Enric Rello
COO & CFO
Sonia Gutierrez
Chief of Clinical Operations
Jordi Xaus
Chief Scientific Officer
Saikat Nandi
Global Chief Business Officer
Emili Torrell
Chief Business Development Officer
Michael Ropacki
Chief Medical Officer, CNS
Neus Virgili
Chief Intellectual Property Officer
Ana Limón
SVP, Clinical Development & Global Medical Affairs